Search Within

Heather Lynn Mcarthur

Formats
  1. Journal Article (41)
  2. Meeting Abstract (40)
  3. Book Section (1)
Groups
  1. Breast Medicine Service (67)
  2. Department of Medicine (67)
  3. Solid Tumor Oncology Division (67)
  4. Survivorship Research (64)
  5. Epidemiology and Biostatistics (47)
  6. Biostatistics Service (45)

More Groups

People
  1. Clifford Hudis (61)
  2. Sujata Patil (40)
  3. Larry Norton (34)
  4. Patrick Morris (22)
  5. Maura Dickler (17)
  6. Stephen Solomon (17)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2018 (1)
  4. 2017 (2)
  5. 2016 (11)
  6. 2015 (10)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Cancer Research (14)
  3. Clinical Cancer Research (4)
  4. Cancer (3)
  5. Clinical Breast Cancer (3)
  6. Journal for ImmunoTherapy of Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (7)
  4. Springer (4)
  5. Wiley Blackwell (4)
  6. Biomed Central Ltd (3)

More Publishers

Results (82)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer
    Meeting Abstract

    Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Vornik, L.; Cornelison, T. L.; Hershman, D. L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Adjuvant trastuzumab reduces locoregional recurrence in women who undergo breast conservation therapy for node-negative HER2-positive breast cancer
    Journal Article

    Kiess, A. P.; Mcarthur, H. L.; Mahoney, K.; Patil, S.; Morris, P. G.; Ho, A.; Hudis, C. A.; McCormick, B.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer
    Journal Article

    Morris, P. G.; Lynch, C.; Feeney, J. N.; Patil, S.; Howard, J.; Larson, S. M.; Dickler, M.; Hudis, C. A.; Jochelson, M.; Mcarthur, H. L.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Update on administration of adjuvant trastuzumab
    Journal Article

    Mcarthur, H. L.
    Clinical Advances in Hematology & Oncology (2010)

    Fulltext@MSK | Save
  • Chemotherapy: Neoadjuvant trial design: Time for a brave new world?
    Journal Article

    Mcarthur, H. L.; Hudis, C. A.
    Nature Reviews Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Evaluation and treatment of breast cancer
    Book Section

    McArthur, H. L.; Hudis, C. A.
    In Stubblefield, M. D.; O'Dell, M. W. (Eds.) Cancer Rehabilitation: Principles and Practice. 1st ed (2009)

    Fulltext@MSK | Save
  • Evaluation of the correlation of baseline blood pressure (BP) and plasma renin activity (PRA) with bevacizumab (B)-mediated hypertension in patients with early-stage breast cancer
    Meeting Abstract

    Dickler, M. N.; McArthur, H. L.; Nulsen, B.; Patil, S.; Sealey, J.; Laragh, J.; Merali, C.; Steingart, R.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction
    Journal Article

    Morris, P. G.; Dickler, M.; Mcarthur, H. L.; Traina, T.; Sugarman, S.; Lin, N.; Moy, B.; Come, S.; Godfrey, L.; Nulsen, B.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: No evidence of short-term changes in left ventricular ejection fraction
    Meeting Abstract

    Morris, P. G.; Dickler, M.; Mcarthur, H.; Traina, T.; Godfrey, L.; Steingart, R.; Rugo, H.; Lin, N.; Moy, B.; Come, S.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H.; Rugo, H.; Nulsen, B.; Traina, T.; Patil, S.; Zhou, Q.; Steingart, R.; Dang, C.; Park, J.; Moasser, M.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save